Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.

CSE:BRAX - Post by User

Braxia Scientific Corp > Jan 10th Dales Report Interview

<< Previous

Bullboard Posts

Next >>

Comment by Marcus319on Jan 11, 2022 4:23pm

154 Views

Post# 34305462

RE:Jan 10th Dales Report Interview

One of the better interviews I've seen with Roger. We've always known he is one of if not the highest regarded in this field. He is very confident that Braxia will be teaming with in one way or another with Big Pharma cmopany(s) in the future. His involvement with pharmacutical companies over many years will be what I believe will drive this company ahead.
JMO

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports